ETERNATEAR
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market. Dry eye is the inability of the tear film and lids to protect the surface of the eye, resulting in itching, burning, and pain. With a dozen or more underlying causes, dry eye is notoriously difficult to diagnose and treat, and if left untreated, it can lead to permanent corneal damage. Patients with even moderate dry eye can suffer from debilitating symptoms that lead to a drastically reduced quality of ... life. Current treatment options are limited, and most patients rely on over-the-counter eye drops for temporary relief. But because they neither treat the root cause nor appropriately address the symptoms, current products on the market fail to provide adequate relief and must be reapplied as often as 6-12 times every day. By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product that is closest to natural tears. Using a previously unrecognized mechanism, EternaTearâ„¢ can remain on the eye for an extended period of time, reducing the number of applications per day and giving Dry Eye patients lasting relief.
ETERNATEAR
Social Links:
Industry:
Health Care Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.eternatear.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Emmetrope
Emmetrope is developing next-generation accommodative lenses.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Upstream Bio
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Current Employees Featured
Founder
Investors List
Tom Vorisek
Tom Vorisek investment in Series A - EternaTear
DeepWork Capital
DeepWork Capital investment in Series A - EternaTear
Carolina Angel Network
Carolina Angel Network investment in Series A - EternaTear
Duke Angel Network
Duke Angel Network investment in Series A - EternaTear
Keiretsu Capital
Keiretsu Capital investment in Series A - EternaTear
Keiretsu Forum
Keiretsu Forum investment in Series A - EternaTear
Band of Angels
Band of Angels investment in Series A - EternaTear
Official Site Inspections
http://www.eternatear.com Semrush global rank: 5.22 M Semrush visits lastest month: 1.56 K
- Host name: 172.67.150.140
- IP address: 172.67.150.140
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EternaTear"
EternaTear - Crunchbase Company Profile & Funding
By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product …See details»
EternaTearâ„¢ | The Next Generation Artificial Tear
By pairing proven technologies with pioneering research, EternaTearâ„¢ is developing a product …See details»
Team | EternaTearâ„¢
He earned a reputation as a team builder who could turn around an organization or business and consistently meet or exceed expectations and performance plans. In 2002 he and his family moved to the Alcon Ft. Worth Texas …See details»
Eternatear Company Profile | Management and Employees List
Jun 30, 2024 Using a previously unrecognized mechanism, EternaTear can remain on the …See details»
EternaTear Company Profile 2024: Valuation, Funding & Investors
EternaTear General Information Description. Developer of over-the-counter artificial tears …See details»
EternaTear's Leadership Team - Team members and org chart
Other teams at EternaTear. View all +8. Board of Directors. 11 members. CEO and Executive …See details»
Eternatear, Inc. Company Profile | Raleigh, NC | Competitors ...
Find company research, competitor information, contact details & financial data for Eternatear, …See details»
EternaTear - Company Profile - Tracxn
Oct 31, 2024 EternaTear ranks 19th among 48 active competitors. 14 of its competitors are …See details»
EternaTearâ„¢ | Med1 Ventures LLC
EternaTearâ„¢ is a group of seasoned healthcare product developers and ophthalmic experts with a proven track record; our team is responsible for developing artificial tears that generate more than $350M in annual revenue. …See details»
EternaTear - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . …See details»
EternaTear's Board of Directors - Team members and org chart
Other teams at EternaTear. View all. CEO and Executive Team. 3 members. Leadership …See details»
Eternatear - Overview, News & Similar companies | ZoomInfo.com
Oct 6, 2020 Eternatear contact info: Phone number: (919) 241-3200 Website: …See details»
EternaTear - VentureRadar
EternaTear’s revolutionary technology works by naturally binding each of the 3 tear film layers …See details»
EternaTear - Contacts, Employees, Board Members, Advisors
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.See details»
EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding
EternaTear is developing a novel artificial tear formulation designed to supplement all layers of …See details»
Gould & Ratner Represents Client EternaTear in Completing ...
Oct 7, 2020 Gould & Ratner, with Fred Tannenbaum as lead partner, and with the help of …See details»
News - EternaTear
EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding. News. RALEIGH, N.C., …See details»
Technology - EternaTear
EternaTear’s revolutionary technology works by naturally binding each of the 3 tear film layers …See details»
News - EternaTear
Oct 12, 2020 EternaTearâ„¢ Raises $4.9 Million in Oversubscribed Series A Funding. by Chris …See details»
Dry Eye | EternaTearâ„¢
Dry Eye affects 320 million people globally, and nearly 15% of the US population; and these …See details»